Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p31 | (1) | ICCBH2013

Craniofacial consequences of high dose zoledronic acid injections in onco-pediatric patients

Lezot Frederic , Chesneau Julie , Battaglia Severine , Brion Regis , Farges Jean-Christophe , Heymann Dominique , Redini Francoise

Background: High doses of zoledronic acid (ZOL), one of the most potent inhibitors of bone resorption; is currently evaluated in a phase III clinical trial in Europe for the treatment of malignant pediatric primary bone tumors. The impact of such an intensive treatment on the craniofacial skeleton is a critical question in the context of patients with actively growing skeleton; in particular in the light of our previous studies evidencing that endochondral bone formation was t...

ba0003pp172 | Cell biology: osteoclasts and bone resorption | ECTS2014

In vitro inhibitory activity on RANKL-mediated osteoclastogenesis of Glossogyne tenuifolia extract

Wang Shih-Wei , Kuo Han-Chun , Hsu Hsia-Fen , Tu Yuan-Kun , Cheng Tien-Tsai , Houng Jer-Yiing

Receptor activator of nuclear factor kappa B ligand (RANKL)-induced activation of NF-κB and MAPKs signaling pathways is critical to osteoclastogenesis. Glossogyne tenuifolia has been used as an antipyretic, detoxication, and anti-inflammatory herb tea in Penghu Island, Taiwan. This study investigated the effects of G. tenuifolia ethanolic extract (GTE) on the formation of RANKL-activating osteoclasts and expression of signaling pathways using a RAW264.7 ...

ba0003pp249 | Osteoporosis: evaluation and imaging | ECTS2014

Prevalence of post-operative medical and surgical complications among fracture neck of femur patients in an acute hip unit

Karim Rehmat , Siddarth K V , Gupta Abhaya

Objective: To assess the prevalence of post-operative medical and surgical complications among fracture neck of femur patients.Method: Study design: retrospective cohort study.Setting: District General Hospital in UK.Study subject: a total of 75 patients with fracture neck of femur from 2012 to 2013 were ascertained for any post-operative complications by case note study.Results: Out of...

ba0003pp336 | Osteoporosis: treatment | ECTS2014

The effect of alendronate oral jelly in the treatment of osteoporosis in clinical settings

Okimoto Nobukazu , Arita Shinobu , Akahoshi Syojiro , Yoshioka Toru , Fuse Yoshifumi

Alendronate is one of the most popular anti-resorptive drugs and widely used to treat osteoporotic patients in the world. In Japan, alendronate oral jelly (ALN-J) as a new formulation was launched in 2013. Dissolution test and bioequivalence study were performed between ALN-J and alendronate oral weekly tablet (ALN-T), and bioequivalence of both drugs was approved. Dosage and administration of ALN-J is the same as ALN-T. Moreover, ALN-J has special features of easy swallowing ...

ba0003pp349 | Osteoporosis: treatment | ECTS2014

Bisphosphonate-associated atypical femoral fracture, effect of teriparatide

Devogelaer Jean-Pierre , Berg Bruno Vande

Long-term bisphosphonate (BP) therapy can be complicated by atypical femoral fracture (AFF). A positive effect of teriparatide (TPTD) has been suggested.A woman (A, 81) with densitometric OP was put on alendronate (ALN) from 1997 until 2006, substituted by ibandronate (IBA), with an increase in FN-BMD of 6.6%. In August 2010, a fall from her standing height provoked a right transverse femoral fracture, which was operated. She was weaned from BP therapy. ...

ba0004is19biog | (1) (1) | ICCBH2015

Rare sclerosing bone dysplasias

Nishimura Gen

Biographical DetailsDr Gen Nishimura is Radiologist-in-Chief, Department of Pediatric Imaging, Tokyo Meteropolitan Children’s Medical Center, Tokyo, Japan. After obtaining the medical degree at Keio University School of Medicine in Tokyo, Dr G Nishimura started his career of diagnostic radiology in the late 1970s. During the exposure to pediatric radiology in early 1980s, he develope...

ba0006p112 | (1) | ICCBH2017

A novel mutation of CYP27B1 in two siblings with vitamin D-dependent rickets type 1A

Orbak Zerrin

: Rickets can occur due to vitamin D deficiency or defects in its metabolism. Mutations in the CYP27B1 gene, which encodes vitamin D 1α-hydroxylase, are the genetic basis of vitamin D-dependent rickets type 1A (VDDR1A, OMIM 264700). Vitamin D dependent rickets type 1 is inherited in an autosomal recessive pattern. We report here a new mutation in CYP27B1, which lead to vitamin D dependent rickets type 1. Two boy siblings from a consanguineous Turkish family presented to e...

ba0007p85 | (1) | ICCBH2019

Neonatal calcinosis cutis due to a mutation in the GNAS gene

Levy-Shraga Yael , Barel Ortal , Javasky Elisheva , Barzilai Aviv , Greenberger Shoshana

Background: Calcinosis cutis, the deposition of insoluble calcium salts in the cutaneous and subcutaneous tissue, is rare during infancy. Calcifications are most frequently reported after subcutaneous fat necrosis, hypothermia in neonates or following extravasation of calcium gluconate.Presenting problem: The patient was born at term by caesarean section because of fetal distress; the birth weight was 2426 g. At age 4 weeks, he was admitted to the hospit...

ba0001pp162 | Cancer and bone: basic, translational and clinical | ECTS2013

Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer: the ZOTECT Study

Hadji Peyman , Ziller May , Maurer Tobias , Autenrieth Michael , Muth Mathias , Ruebel Amelie , May Christoph , Birkholz Katrin , Diebel Erhardt , Gleissneer Jochen , Rothe Peter , Gschwend Juergen E

Introduction: The prospective, single-arm, open-label ZOTECT study was designed to assess the effect of zoledronic acid (ZOL) on bone-marker levels and potential correlations with disease outcomes in bisphosphonate-naive patients with bone metastases.Methods: Patients with bone metastases from prostate cancer (PC; n=301) or breast cancer (BC; n=99) who have not received bisphosphonates for ≥6 months were enrolled at 98 sites in Ge...

ba0001pp253 | Chondrocytes and cartilage | ECTS2013

Can adrenomedullin be a potential osteoarthritis treatment?

Chatron-Colliet Aurore , Velard Frederic , Come Dominique , Lin Hilene , Ea Hang Korng , Liote Frederic

Objective: Chondrolysis, chondrocyte apoptosis, and local inflammation are described to exacerbate osteoarthritis development. We therefore aimed to investigate the effect of adrenomedullin (ADM) and its truncated peptide (22–52ADM) on in vitro and in vivo models. Both have exhibited anti-apoptotic and anti-inflammatory properties in collagen-induced arthritis (CIA) in mice.Methods: In normoxia or hypoxia (physiological condition),...